Patent AnalyticsExaminers
Rankings

Company or institution

DAIICHI SANKYO COMPANY, LIMITED

686 applicationsfiled 2006 to 2026

Allowance rate
67%
−8 pts vs the USPTO range 64% to 71%
Rejections before allowance
1.5
level with the USPTO
Months to first action
14.2 mo
−4.4 vs the USPTO
Needed an RCE
23%
−4 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations261 apps
C07D Heterocyclic compounds206 apps
C07K Peptides87 apps
A61P Therapeutic activity of compounds42 apps
C12N Microorganisms or enzymes23 apps
C07C 17 apps

Art units

162597 apps
162654 apps
164642 apps
162839 apps
162435 apps
OPAP35 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19617682COMBINATION OF ANTI-EGFR ANTIBODY-DRUG CONJUGATE AND ADDITIONAL AGENT2026-08-22Pending00n/a
19617683COMBINATION OF ANTI-CDH6 ANTIBODY-DRUG CONJUGATE AND ADDITIONAL AGENT2026-08-22Pending00n/a
19609445COMBINATION OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND ADDITIONAL AGENT2026-07-24Pending00n/a
15497461Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15677111Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15553776Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15995248Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15997100Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15519768Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15273618Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 686 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in